⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Official Title: A Randomized, Double-Blind, Placebo Controlled Phase 3 Study of Venetoclax Co-Administered With Low Dose Cytarabine Versus Low Dose Cytarabine in Treatment Naïve Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Study ID: NCT03069352

Study Description

Brief Summary: The primary objective of this study is to evaluate if venetoclax when co administered with low-dose cytarabine (LDAC) improves overall survival (OS) versus LDAC and placebo, in treatment-naïve patients with acute myeloid leukemia (AML).

Detailed Description: Acute myeloid leukemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible for fighting infections). Successful treatment of AML is dependent on what subtype of AML the patient has, and the age of the patient when diagnosed. Venetoclax is an experimental drug that kills cancer cells by blocking a protein (part of a cell) that allows cancer cells to stay alive. This study is designed to see if adding venetoclax to cytarabine works better than cytarabine on its own. This is a Phase 3, randomized, double-blind (treatment unknown to patients and doctors), placebo-controlled, multicenter study in patients with AML who are 18 or more years old and have not been treated before. Patients who take part in this study should not be suitable for intensive induction chemotherapy (usual starting treatment). Abbvie is funding this study which will take place at approximately 125 hospitals globally. In this study, 2/3 of patients will receive venetoclax every day with cytarabine and the remaining 1/3 will receive placebo (dummy) tablets with cytarabine. Participants will continue to have study visits and receive treatment for as long as they are having a clinical benefit. The effect of the treatment on AML will be checked by taking blood, bone marrow, scans, measuring side effects and by completing health questionnaires. Blood and bone marrow tests will be completed to see why some people respond better than others.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

H. Lee Moffit Cancer Center /ID# 164273, Tampa, Florida, United States

Norton Cancer Institute /ID# 158998, Louisville, Kentucky, United States

Univ of Pittsburgh Med Ctr /ID# 158997, Pittsburgh, Pennsylvania, United States

Univ TX, MD Anderson /ID# 159678, Houston, Texas, United States

Swedish Medical Center /ID# 161280, Seattle, Washington, United States

Gundersen Health System /ID# 164272, La Crosse, Wisconsin, United States

Cemic /Id# 159676, Buenos Aires, , Argentina

Sanatorio Allende /ID# 159675, Cordoba, , Argentina

Calvary Mater Newcastle /ID# 160123, Waratah, New South Wales, Australia

Westmead Hospital /ID# 160121, Westmead, New South Wales, Australia

Alfred Hospital /ID# 160125, Melbourne, Victoria, Australia

Box Hill Hospital /ID# 162920, Melbourne, Victoria, Australia

Universitair Ziekenhuis Antwerpen /ID# 159566, Edegem, Antwerpen, Belgium

Cliniques Universitaires Saint Luc /ID# 159567, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium

Centro de Pesquisas Oncologicas /ID# 163567, Florianopolis, Santa Catarina, Brazil

Hospital de Cancer de Barretos /ID# 163568, Barretos, Sao Paulo, Brazil

Hospital do Cancer Mae de Deus /ID# 163416, Porto Alegre, , Brazil

Casa de Saúde Santa Marcelina /ID# 163413, Sao Paulo, , Brazil

University of Alberta Hospital /ID# 159646, Edmonton, Alberta, Canada

CISSS de la Monteregie /ID# 159782, Greenfield Park, Quebec, Canada

Hospital Maisonneuve-Rosemont /ID# 159780, Montreal, Quebec, Canada

Hopital Sacre Coeur Montreal /ID# 160982, Montreal, Quebec, Canada

Fujian Medical Univ Union Hosp /ID# 167321, Fuzhou, Fujian, China

Nanfang Hospital of Southern Medical University /ID# 170147, Guangzhou, Guangdong, China

Jiangsu Province People's Hospital /ID# 167511, Nanjing, Jiangsu, China

The First Hosp of Jilin Univ /ID# 167512, Changchun, Jilin, China

Ruijin Hospital, Shanghai Jiaotong /ID# 167325, Shanghai, Shanghai, China

West China Hospital /ID# 167514, Chengdu, Sichuan, China

Blood disease hosp of Chinese Academy of Med Sciences(Institute of Hematology) /ID# 167509, Tianjin, Tianjin, China

The First Affiliated Hospital,College of Medicine, Zhejiang University /ID# 167324, Hangzhou, Zhejiang, China

Qilu Hospital of Shandong Univ /ID# 167507, Jinan, , China

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 167515, Wuhan, , China

Henan Cancer Hospital /ID# 167327, Zhengzhou, Henan, , China

Fakultni Nemocnice Brno /ID# 159247, Brno, , Czechia

Univ Hosp Ostrava-Poruba /ID# 159246, Ostrava, , Czechia

Fakult Nem Kralovske Vinohrady /ID# 159248, Prague, , Czechia

Centre Hospitalier Lyon Sud /ID# 159705, Pierre Benite CEDEX, Rhone, France

Centre Hospitalier Le Mans /ID# 159702, Le Mans CEDEX 9, Sarthe, France

Centre Hospitalier de la Cote /ID# 159697, Bayonne, , France

CHU Bordeaux /ID# 159704, Pessac, , France

CHU De Nancy /ID# 159700, Vandoeuvre Les Nancy Cedex, , France

Schwarzwald-Baar-Klinikum /ID# 159571, Villingen-Schwenningen, Baden-Wuerttemberg, Germany

Vivantes Klinikum Am Urban /ID# 159569, Berlin, , Germany

Universitaetsklinikum Hamburg /ID# 161760, Hamburg, , Germany

General Hospital of Athens Laiko /ID# 157870, Athens, Attiki, Greece

Gen Univ Hosp Alexandroupolis /ID# 157868, Alexandroupolis, , Greece

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 157869, Athens, , Greece

University Gen Hosp of Patra /ID# 157871, Patras, , Greece

General Hospital of Thessaloniki George Papanikolaou /ID# 157867, Thessaloniki, , Greece

Dél-pesti Centrumkórház- Országos Hematológiai és Infektológiai Intézet /ID# 159127, Budapest IX, Budapest, Hungary

Pecsi Tudomanyegyetem /ID# 163161, Pécs, Pecs, Hungary

Semmelweis Egyetem I. Belklini /ID# 158180, Budapest, , Hungary

Debreceni Egyetem Klinikai Koz /ID# 158178, Debrecen, , Hungary

Petz Aladar Megyei Oktato Korh /ID# 161739, Gyor, , Hungary

Kaposi Mor Oktato Korhaz /ID# 158175, Kaposvar, , Hungary

Bacs-Kiskun Megyei Korhaz /ID# 160973, Kecskemét, , Hungary

St. James's Hospital /ID# 162730, Dublin 8, Dublin, Ireland

Beaumont Hospital /ID# 162733, Dublin, , Ireland

University Hospital Galway /ID# 162734, Galway, , Ireland

University Hospital Limerick /ID# 162735, Limerick, , Ireland

University of Fukui Hospital /ID# 159770, Yoshida-gun, Fukui, Japan

Kyushu University Hospital /ID# 159688, Fukuoka-shi, Fukuoka, Japan

Gunmaken Saiseikai Maebashi Hospital /ID# 160597, Maebashi-shi, Gunma, Japan

National Hospital Organization Mito Medical Center /ID# 162988, Higashi Ibaraki-gun, Ibaraki, Japan

Kyoto Prefect Univ Med /ID# 160101, Kyoto-shi, Kyoto, Japan

Tohoku University Hospital /ID# 161151, Sendai-shi, Miyagi, Japan

Nagasaki University Hospital /ID# 160233, Nagasaki-shi, Nagasaki, Japan

Osaka City University Hospital /ID# 159722, Osaka-shi, Osaka, Japan

Kinki University -Osakasayama Campus /ID# 160777, Osakasayama-shi, Osaka, Japan

Tokyo Metropolitan Komagome Hospital /ID# 160759, Bunkyo-ku, Tokyo, Japan

Tokyo Jikei Daisan Hospital /ID# 159769, Komae-shi, Tokyo, Japan

NTT Medical Center Tokyo /ID# 160678, Shinagawa-ku, Tokyo, Japan

Yamagata University Hospital /ID# 161223, Yamagata-shi, Yamagata, Japan

Akita University Hospital /ID# 160602, Akita, , Japan

Saitama Med Univ Int Med Ctr /ID# 161308, Hidaka, , Japan

NHO Nagoya Medical Center /ID# 159768, Nagoya, , Japan

Dokkyo Medical University Hosp /ID# 159650, Shimotsuga, , Japan

Juntendo University Hospital /ID# 159781, Tokyo, , Japan

Pusan National University Hosp /ID# 158725, Busan, Busan Gwang Yeogsi, Korea, Republic of

Chungnam National University Hospital /ID# 158726, Jung-gu, Daejeon Gwang Yeogsi, Korea, Republic of

Cath Univ Seoul St Mary's Hosp /ID# 158724, Seoul, Seoul Teugbyeolsi, Korea, Republic of

Seoul National University Hospital /ID# 162253, Seoul, , Korea, Republic of

Instituto Nacional de Cancerol /ID# 159269, Ciudad de México, Ciudad De Mexico, Mexico

Centro de Invest Clin Chapulte /ID# 162625, Morelia, Michoacan, Mexico

Hosp. Univ. Dr. Jose E. Gonz /ID# 159268, Monterrey, Nuevo Leon, Mexico

North Shore Hospital /ID# 160132, Auckland, , New Zealand

Middlemore Clinical Trials /ID# 160131, Auckland, , New Zealand

Haukeland University Hospital /ID# 165630, Bergen, Hordaland, Norway

Sykehuset Ostfold Kalnes /ID# 165632, Gralum, , Norway

VA Caribbean Healthcare System /ID# 158999, San Juan, , Puerto Rico

Kemerovo Regional Clinical Hospital n.a. S.V. Belyaev /ID# 162991, Kemerovo, Kemerovskaya Oblast, Russian Federation

Nizhniy Novgorod regional clinical hospital named N. A. Semashko /ID# 163186, Nizhnij Novgorod, Nizhegorodskaya Oblast, Russian Federation

State Institution of Health of the Ryazan Regional Clinical Hospital /ID# 163126, Ryazan, Ryazanskaya Oblast, Russian Federation

City Clinical Hospital Botkina /ID# 164086, Moscow, , Russian Federation

Samara State Medical Universit /ID# 164173, Samara, , Russian Federation

Almazov North-West Federal Med /ID# 162170, Sankt-peterburg, , Russian Federation

saratov state medical /ID# 163130, Saratov, , Russian Federation

Saint Petersburg State Institu /ID# 162171, St. Petersburg, , Russian Federation

Yaroslavl Regional Clinic Hosp /ID# 162172, Yaroslavl, , Russian Federation

Netcare Pretoria East Hospital /ID# 157373, Pretoria, Gauteng, South Africa

Tshwane District Hospital /ID# 157361, Pretoria, Gauteng, South Africa

Hospital Universitario y Politecnico La Fe /ID# 161181, Valencia, Valenciana, Spain

Hospital Infanta Leonor /ID# 161180, Madrid, , Spain

National Taiwan Univ Hosp /ID# 162781, Taipei City, Taipei, Taiwan

Tri-Service General Hospital /ID# 161683, Taipei City, Taipei, Taiwan

Kaohsiung Medical University /ID# 161693, Kaohsiung, , Taiwan

Heartlands Hospital /ID# 163534, Birmingham, , United Kingdom

University Hospital of Wales /ID# 162726, Cardiff, , United Kingdom

Northwick Park Hospital /ID# 162727, Harrow, , United Kingdom

Contact Details

Name: AbbVie Inc.

Affiliation: AbbVie

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: